Basic Materials / Specialty ChemicalsJakartaID
$178.00
+5.00 (+2.89%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 25%
FCF escenarios
weak_data · normalized FCF $50.1B · quality 62.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
40/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$450.4B
P/E
N/A
•EV/EBITDA
N/A
•ROE
3.5%
↑Gross Margin
23.4%
↑Debt/Equity
0.01
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2013–2025 · 12 años de histórico normalizado
Revenue CAGR
+2.5%
FCF CAGR
—
FCF margin
11.6%
FCF / Net income
1.08x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $319.17B · net income $34.41B · FCF $37.16B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||
| Revenue | $319.17B | $319.17B | $344.46B | $470.70B | $486.88B | $397.31B | $349.98B | $349.58B | $399.19B | $368.17B | $339.99B | $304.39B | $284.17B | $236.57B |
| Net Income | $34.41B | $34.41B | $27.55B | $47.80B | $37.95B | $38.71B | $39.84B | $32.46B | $33.51B | $46.85B | $86.69B | $5.63B | $4.36B | $9.31B |
| EBITDA | $55.12B | $55.12B | $54.26B | $79.55B | $65.29B | $62.46B | $65.31B | $57.78B | $58.58B | $71.98B | $98.60B | $35.52B | $30.40B | $25.89B |
| EPS | 13.60 | 13.60 | 10.89 | 18.89 | 15.00 | 15.30 | 15.75 | 12.83 | 13.24 | 14.45 | 34.26 | 2.22 | 2.07 | 4.43 |
| Gross Margin | 23.4% | 23.4% | 21.0% | 22.5% | 20.1% | 21.5% | 24.2% | 22.8% | 19.6% | 23.7% | 32.9% | 6.6% | 7.7% | 14.9% |
| Operating Margin | 11.4% | 11.4% | 8.6% | 11.9% | 9.5% | 9.6% | 13.4% | 10.0% | 9.3% | 15.0% | 24.6% | -4.0% | 0.6% | 6.9% |
| Net Margin | 10.8% | 10.8% | 8.0% | 10.2% | 7.8% | 9.7% | 11.4% | 9.3% | 8.4% | 12.7% | 25.5% | 1.8% | 1.5% | 3.9% |
| Balance Sheet | ||||||||||||||
| Debt/Equity | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.71 | 0.95 | 0.96 |
| Current Ratio | 9.01 | 9.01 | 11.48 | 6.15 | 5.38 | 7.86 | 9.28 | 7.05 | 7.02 | 4.45 | 2.12 | 1.09 | 1.06 | 1.42 |
| Cash Flow | ||||||||||||||
| Free Cash Flow | $37.16B | $37.16B | $50.14B | $60.29B | $-20.45B | $23.49B | $58.84B | $25.73B | $24.93B | $-1.60B | $84.76B | $37.12B | $-18.23B | $-98.20B |
| Returns | ||||||||||||||
| ROE | 3.5% | 3.5% | 2.9% | 5.0% | 4.1% | 4.4% | 4.6% | 4.0% | 4.1% | 6.3% | 36.8% | 4.4% | 3.5% | 7.4% |
| Growth & Yield | ||||||||||||||
| Revenue Growth | -7.3% | -7.3% | -26.8% | -3.3% | 22.5% | 13.5% | 0.1% | -12.4% | 8.4% | 8.3% | 11.7% | 7.1% | 20.1% | — |
| EPS Growth | 24.9% | 24.9% | -42.4% | 25.9% | -2.0% | -2.8% | 22.7% | -3.1% | -8.4% | -57.8% | 1440.1% | 7.3% | -53.2% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
5.1%
EPS terminal req.
$15.79
Spread vs growth
19.8%
5Y implied EPS CAGR
7.0%
EPS terminal req.
$19.11
Spread vs growth
17.9%
10Y implied EPS CAGR
8.5%
EPS terminal req.
$30.78
Spread vs growth
16.4%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+7.9%
Start / end P/E
15.2x → 13.1x
EPS bridge
10.89 → 13.60
Residual
-3.4%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.